KAP, CAFCA and Stadio shine; Exxaro and Blu Label under pressure on Friday

Friday's trade on the JSE was a story of two markets: resource and materials stocks held firm as energy names faltered, while financials and industrials dragged the broader board lower. The All Share closed down 0.05%, with the Resource 20 up 0.84% and Basic Materials gaining 0.78%, while the Financial 15 shed 0.55% and Industrials 25 slipped 0.31%. On the upside, KAP rallied 7.5% after blowing past its own profit guidance, and DNB was the top performer overall at 9.0%, though the day was also marked by notable weakness in Gemfields (down 11.1% in thin trade) and EPE Capital Partners (down 7.9%).

KAP HEPS blows past guidance floor despite R1bn impairment shadow

KAP Limited trading statement guided headline earnings per share of 43.8 to 46.2 cents for the first half, representing 82 to 92 percent growth and materially exceeding the company's own prior floor of 36.2 cents that had been set as recently as 12 June. The share had sold off into the print, meaning the stronger figures arrived as a genuine positive rather than confirmation of a known result. Underlying operating cash generation was strong enough to reduce net debt by more than R1 billion, doubling the R500 million full-year target that the market had been tracking.

The shadow over the print is the R1 billion in impairments at Restonic, Safripol and Optix that drove EPS to a loss of 3.8 to 6.2 cents, compared with 0.4 cents in the prior year. These impairments do not flow through headline earnings, which is the operating measure the market uses for KAP, but they are real non-cash charges against equity. Safripol's impairment reflects a global polymer cycle that the company expects to persist beyond 2030, suggesting long-duration structural margin pressure in that division, while Optix's Australian operations continue to underperform on pipeline conversion.

The balance sheet improvement through the R1 billion net debt reduction is the clearest positive in the filing, and the operating momentum in the HEPS beat is scored. But the market will want the audited results to confirm whether the impairment cycle is largely complete or whether further write-downs are on the horizon, and to verify that the operating cash generation fully backs the headline earnings.

EXX Equity-accounted drag pulls HEPS down 18–23%

Exxaro Resources trading statement guided headline earnings per share of 1,327 to 1,414 cents for the first half, down 18 to 23 percent from the 1,724 cents recorded in the prior year. The deterioration is driven by lower income from equity-accounted investments at SIOC, the company's iron ore stake, and BMM, which operates the Gamsberg zinc project. The owned coal engine, by contrast, is expected to deliver core EBITDA broadly in line with the prior period, meaning the underlying operating business is holding its ground.

At SIOC, the weakness reflects a combination of Rand strength and cost inflation driven by Middle East conflict, both of which sit outside management control and could deepen if either variable worsens. At BMM, the issue is a delayed ramp-up of the Gamsberg project, which Exxaro describes as a temporary cost-and-volume overhang that should normalise as the operation reaches steady state. The market will need to assess on 20 August whether that normalisation timeline is credible or whether the drag is more structural in nature.

The share had already sold off 7.8 percent in the twenty days before the print, suggesting the market had begun pricing the negative guidance ahead of time. The reviewed results due on 20 August will test whether the core EBITDA flatness holds up under scrutiny and whether the equity-accounted drag is transient, while also giving investors clarity on the net debt and capex position heading into the second half of the year.

SDO Double-digit earnings growth confirmed after pre-announcement sell-off

Stadio Holdings voluntary trading statement showed headline earnings per share and HEPS of 23.2 to 24.8 cents for the first half, up 11.5 to 19.2 percent year-on-year. Core HEPS, which strips out non-recurring items, is guided at 23.7 to 25.3 cents, representing growth of 14.5 to 22.2 percent. The voluntary nature of the update is notable: Stadio chose to publish ahead of any mandatory requirement, and the figures delivered the kind of clear directional signal that a voluntary disclosure is designed to convey.

The context matters for the reading. In the twenty days before the announcement, the share had sold off 10.3 percent, meaning the positive figures landed as fresh news rather than stale confirmation. The Core HEPS range running above the headline HEPS range signals genuine underlying operational momentum rather than accounting relief. The 8-point guidance band still signals meaningful uncertainty, but the direction of travel is unambiguously positive.

The audited first half results are due on 28 August and will be the test that matters. The voluntary statement provides no cash flow, debt, capex or enrolment data, so the market cannot yet assess whether the double-digit growth is backed by real operational scale and cash conversion. The direction is set; the quality will be confirmed or qualified in three weeks.

CAC Q3 volume acceleration to 32% drives 147% pretax profit surge

CAFCA Q3 trading update shows volumes up 32 percent year-on-year, accelerating sharply from the 20 percent year-to-date rate that had been the running pace through the first two quarters. Pretax profit is 147 percent ahead of the prior year, a surge that reflects genuine operating leverage as revenue grew 31 percent while the business managed to contain costs against a backdrop of significant input price inflation. The share had drifted mildly into the print, so the strong figures arrived as new information the market had not pre-positioned for.

Year-to-date revenue grew 31 percent, supported by both a 20 percent rise in sales volumes and pricing taken in sympathy with input cost inflation. Both domestic and export channels strengthened: local sales rose 21 percent and exports gained 8 percent, broadening the revenue base. Raw material costs, however, rose 36 percent year-to-date, outpacing the 31 percent revenue growth and narrowing the price-cost spread. That is the legitimate concern in the filing: if input cost pass-through stalls, the margin structure that produced the 147 percent pretax profit gain is at risk.

The filing provides no cash flow, net debt or margin disclosure, leaving the pretax surge's earnings quality and capital structure unverified. The next set of interim accounts will be needed to confirm that the profit growth is cash-backed and that the narrowing price-cost spread does not signal forward margin erosion. The Q3 acceleration is the clearest positive signal in the filing, but the margin question is live.

BLU Underlying business deteriorates 84% even outside Cell C overhang

Blu Label Unlimited trading statement guided headline earnings per share of 79 to 88 cents for the year to May 2026, down 81 to 83 percent from the prior year, with Core HEPS of approximately 75.33 cents against 461.63 cents in the prior year. The company attributes the decline to Cell C restructuring accounting effects, but stripping those out leaves the ex-Cell C business delivering Core HEPS of 75.33 cents versus 461.63 cents previously reported, a structural step-down in earnings that the Cell C narrative does not fully explain.

The underlying ex-Cell C operations generated R9.4 billion in revenue, R923 million in EBITDA and R677 million in net profit after tax. Those are real numbers, but they represent an enormous step-down from the prior year and raise questions about whether the core distribution franchise is structurally shrinking or merely cycling through a one-off earnings pressure. The rebrand to Blu Label Unlimited Group distances the identity from the Cell C overhang but does not restore the earnings base on its own.

No cash flow, debt or segment breakdown is provided in the trading statement, leaving investors unable to assess the quality or durability of the R677 million underlying net profit. The August audited results will be the market's first real opportunity to test whether the earnings base is defensible or at further risk, and whether any further impairments or Cell C-linked write-downs remain outstanding.

EEL Liquidation deferred as board pursues undefined recapitalisation

Efora Energy Limited has deferred its provisional liquidation court application in order to pursue a potential recapitalisation transaction. The board's decision to engage a prospective capital provider is preferable to capitulating to an immediate insolvency order, and the deferral removes the most acute near-term risk. However, the filing discloses no counterparty, no deal structure and no terms, leaving the market entirely unable to assess whether any transaction could actually resolve a balance sheet severe enough to have triggered liquidation proceedings in the first place.

The company is not in a position to provide financials, cash flow or debt details in this announcement, which means investors have no basis to assess solvency odds or the likelihood that a viable recapitalisation can be concluded. The binary outcome framing remains accurate: either a credible transaction emerges, or the liquidation process resumes. There is no middle ground disclosed, and no timeline has been given for when the market should expect a resolution.

Any further SENS announcement will be the next material data point for investors. The deferral buys time, but it does not resolve the underlying crisis, and without a named counterparty or stated terms, the market cannot reprice the situation as either significantly better or worse than it was before the announcement.

GTC Controlling shareholder Optima reviews strategic options

Globe Trade Centre S.A. disclosed that its indirect majority shareholder Optima, which holds 62.61 percent of the company through Dutch and Hungarian vehicles, has begun a formal review of strategic options. The options on the table include a potential sale of the stake, a capital increase or a joint public tender offer. No decision has been made, no counterparty identified and no terms disclosed. The filing explicitly lists a public tender offer as a structural option, which would be the outcome most material to SA retail investors as it would give minority shareholders a defined exit price.

This is a real strategic event: a controlling shareholder holding more than 60 percent of a company formally reviewing its options is not a routine or trivial development. However, the review is at an early stage, and the market cannot yet assess whether any eventual transaction would be value-accretive or dilutive for minorities. The absence of a named counterparty or stated consideration means the deal cannot be scored as a catalyst at this point.

South African investors holding GTC on the JSE should note that a public tender offer, if it materialises, would be the most direct mechanism affecting their position. Until terms and a counterparty are disclosed, the market is left with the strategic optionality premium but no concrete basis for repricing the share in either direction.

EPS $362,000 cash against $67.9 million working capital deficit

Eastern Platinum Q2 results show deterioration across every key metric. Revenue fell 26 percent year-on-year to $7.9 million, the gross margin collapsed from positive 3 percent to negative 53 percent, and the net loss widened to $6.1 million from $1.8 million. PGM production fell 35.8 percent and chrome concentrate output dropped 24.5 percent, with 78 to 80 percent of revenue dependent on a single Impala Platinum offtake agreement. This is not presented as a cyclical blip but as a structural step-down in operating capacity.

The most critical figure in the filing is the cash position: $362,000 in cash against a $67.9 million working capital deficit. That funding gap is acute and the filing does not disclose a specific remedy or financing plan alongside it. The year-to-date operating loss narrowed to $10.2 million from $11.1 million, which is the one partial positive, but it does not alter the primary reading of a company burning cash in a deteriorating operational environment.

The Zandfontein underground ramp-up is cited as the key operational catalyst to watch. The next update will need to demonstrate whether that project is lifting production volumes and whether a credible funding plan for the working capital deficit exists. Without both, the market faces a binary outcome in which the current quarter's deterioration may only be the start of a more severe stress event. Gemfields, which fell 11.1 percent in thin trade on the day, is flagged as a thinly traded mover with no standalone financial catalyst disclosed.

What we are watching

Next week brings reviewed first half results from Exxaro on 20 August, with Stadio's audited first half accounts due on 28 August. Investors in Blu Label and Eastern Platinum will be watching for the respective audited filings that are the market's primary test of the earnings and funding situations disclosed in the trading statements.